Vioxx Liability Exposure May Exceed 5-Year Product Sales Of $12 Bil.
Merck's liability exposure from Vioxx could exceed total sales of the COX-2 inhibitor from its five years on the market
Merck's liability exposure from Vioxx could exceed total sales of the COX-2 inhibitor from its five years on the market